慢性鼻炎的管理与或没有鼻多重症
Dylan Vance1, Seong Cho2, Amber U Luong3
1Department of Otorhinolaryngology-Head and Neck Surgery, McGovern Medical School, Houston, TX, USA.
Immunology and allergy clinics of North America
|November 15, 2025
概括
慢性鼻炎 (CRS) 是一种复杂的疾病,有不同的类型. 鼻息肉CRS通常涉及2型炎症,治疗CRS可以改善同时存在的喘.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 慢性鼻炎 (CRS) 呈现多种表型,特别是带鼻息肉的CRS (CRSwNP) 和没有鼻息肉的CRS (CRSsNP).
- CRSwNP经常表现出2型炎症,标志着埃索诺菲尔和特定的细胞因子,如IL-4,IL-5和IL-13.
- 虽然CRS不是主要的传染病,但它可能会因感染或微生物失衡而恶化.
研究的目的:
- 确定CRS,特别是CRSwNP的表型特征.
- 探索CRS所涉及的炎症途径.
- 调查CRS和喘之间的关系,以及CRS治疗对喘控制的影响.
主要方法:
- 将CRS患者的表型分类为CRSwNP和CRSsNP组.
- 分析炎症标志物,包括乙氨基酸细胞数量和2型细胞因子概况.
- 评估CRS和喘之间的关联,以及CRS管理对喘症状的影响.
主要成果:
- 大多数CRSwNP病例的特征是2型炎症.
- CRS与喘有关,CRSwNP与喘之间有着显著的联系.
- 有效的CRS治疗对同时患有喘的患者有好处.
结论:
- CRS是一种异质的炎症状况,其中2型炎症是CRSwNP的关键特征.
- CRSwNP与喘之间的强烈关联凸显了综合管理方法的必要性.
- 对CRS的治疗干预可以对喘患者的呼吸系统健康产生积极影响.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Pharyngitis
10.7K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
10.7K
Cystic Fibrosis: Management
457
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
457
COPD: Management Using Bronchodilators and Corticosteroids
709
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
709
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K
Drugs Used in Upper Respiratory Disorders: Overview
611
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
611


